Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose ...

When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price lowered by equities researchers at Citigroup from ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

Both have added billions of dollars in additional revenue for these pharmaceutical leaders ... Over the last year, Eli Lilly’s stock is up a very respectable +25% which has roughly matched ...

What caused Eli Lilly's stock to fall this week ... remains one of the most rock-solid investment opportunities in the pharmaceutical arena. Beyond weight loss, the company has a flourishing ...

2024 was an interesting year for pharmaceutical powerhouse Eli Lilly ... is a good opportunity to buy the dip. What caused Eli Lilly's stock to fall this week? During an earnings report ...